Connect with us

Medical Research

New Study: Post Medical Marijuana Treatment, Many Patients Have Ceased Taking Benzodiazepines

Beth Jenkins



New Study: Post Medical Marijuana Treatment, Many Patients Have Ceased Taking Benzodiazepines
- Ad -

A new study reports that almost half of patients using marijuana to alleviate their respective medical conditions have ceased taking their prescribed benzodiazepines.

The authors of the study reported that, “within a sample of 146 patients who had started out on a medical marijuana treatment regimen, 45.2% discontinued their pre-existing treatment with benzodiazepine with success.” ‘The study concluded that this observation deserves further investigation focusing on the benefits and risks of using medical cannabis in therapy and how this relates to the use of benzodiazepine.’

Significantly, the new study suggests that, neurological patients who take Xanax, Valium and similar popular tranquilizers, may get relief using marijuana. Such conditions include seizures, insomnia and anxieties. There has been a lot of research focused on understanding the possibility of medical cannabis replacing opioids in patients having chronic pain and other problems. These findings were published last month in the Cannabis and Cannabinoid Research journal.

Moreover, Canadian researchers also studied 146 patients who regularly took benzodiazepines at the start of a cannabis therapy program. Significantly, they found that 44 of these (accounting for 30 percent) had stopped taking benzodiazepines by the time of their first visit for follow-up. Overall, 66 patients, representing 45%, ceased taking benzodiazepines on starting their medical cannabis treatment program.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email